Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2013

01.11.2013 | Laboratory Investigation

Trends in childhood brain tumor incidence, 1973–2009

verfasst von: Roberta McKean-Cowdin, Pedram Razavi, Jessica Barrington-Trimis, Rachel Tobias Baldwin, Shahab Asgharzadeh, Myles Cockburn, Tarik Tihan, Susan Preston-Martin

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

In the mid-1980s, there was a rise in incidence rates of childhood brain tumors (CBT) in the United States that appeared to stabilize at a higher rate in the early 1990s. An updated analysis of the pattern of CBT over the past 2 decades, with commentary on whether the elevated incidence rate has continued, is past due. We used Surveillance, Epidemiology and End Results (SEER) data to examine trends in incidence of CBT from 1973 through 2009. We examined age-adjusted incidence rates (AAIRs) and secular trends for all malignant brain tumors combined (SEER classification) by histologic tumor type and anatomic site. The incidence of CBT remained stable from 1987 to 2009 [annual percent change (APC) = 0.10; 95 % confidence intervals (CI) −0.39 to 0.61] with an AAIR for all CBT of 3.32 (95 % CI 3.22–3.42). The stability of rates in these two decades contrast the change that occurred in the mid-1980s (1983–1986), when the incidence of CBT increased by 53 % (APC = 14.06; 95 % CI 4.05–25.0). From 1983 to 1986, statistically significant rate increases were observed for pilocytic astrocytoma, PNET/medulloblastoma, and mixed glioma. Further, the rate of increase in pilocytic astrocytoma was similar to the rate of decrease for astrocytomas NOS from 1981 to 2009, suggesting a change from a more general to more specific classification. After the increase in rates in the mid-1980s, rates of CBT over the past two decades have stabilized. Changes in incidence rates of subtypes of tumors over this time period reflect changes both in classification of CBT and in diagnostic techniques.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278–299PubMedCentralPubMed Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278–299PubMedCentralPubMed
4.
5.
Zurück zum Zitat Smith MA, Freidlin B, Ries LA, Simon R (1998) Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90:1269–1277PubMedCrossRef Smith MA, Freidlin B, Ries LA, Simon R (1998) Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90:1269–1277PubMedCrossRef
6.
Zurück zum Zitat Steinberg EP (1986) The status of MRI in 1986: rates of adoption in the United States and worldwide. AJR Am J Roentgenol 147:453–455PubMedCrossRef Steinberg EP (1986) The status of MRI in 1986: rates of adoption in the United States and worldwide. AJR Am J Roentgenol 147:453–455PubMedCrossRef
7.
Zurück zum Zitat Mack TM (1977) Cancer surveillance program in Los Angeles County. Natl Cancer Inst Monogr 47:99–101PubMed Mack TM (1977) Cancer surveillance program in Los Angeles County. Natl Cancer Inst Monogr 47:99–101PubMed
8.
Zurück zum Zitat Fritz AG (2000) International classification of diseases for oncology: ICD-O. World Health Organization, Geneva Fritz AG (2000) International classification of diseases for oncology: ICD-O. World Health Organization, Geneva
9.
Zurück zum Zitat Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351PubMedCrossRef Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351PubMedCrossRef
10.
Zurück zum Zitat Yu B, Barrett MJ, Kim H-J, Feuer EJ (2007) Estimating joinpoints in continuous time scale for multiple change-point models. Comput Stat Data Anal 51:2420–2427CrossRef Yu B, Barrett MJ, Kim H-J, Feuer EJ (2007) Estimating joinpoints in continuous time scale for multiple change-point models. Comput Stat Data Anal 51:2420–2427CrossRef
11.
Zurück zum Zitat Liu L, Deapen D, Bernstein L (1998) Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control 9:369–380PubMedCrossRef Liu L, Deapen D, Bernstein L (1998) Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control 9:369–380PubMedCrossRef
12.
Zurück zum Zitat Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL (1996) Trends in cancer incidence among children in the U.S. Cancer 78:532–541PubMedCrossRef Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL (1996) Trends in cancer incidence among children in the U.S. Cancer 78:532–541PubMedCrossRef
13.
Zurück zum Zitat Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS (1999) Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382–1390PubMedCrossRef Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS (1999) Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 91:1382–1390PubMedCrossRef
14.
Zurück zum Zitat Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK (2011) Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103:714–736. doi:10.1093/jnci/djr077 PubMedCentralPubMedCrossRef Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK (2011) Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103:714–736. doi:10.​1093/​jnci/​djr077 PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Poussaint TY (2001) Magnetic resonance imaging of pediatric brain tumors: state of the art. Top Magn Reson Imaging 12:411–433PubMedCrossRef Poussaint TY (2001) Magnetic resonance imaging of pediatric brain tumors: state of the art. Top Magn Reson Imaging 12:411–433PubMedCrossRef
16.
Zurück zum Zitat Zulch K (1979) Histological typing of tumors of the central nervous system. World Health Organization, Geneva Zulch K (1979) Histological typing of tumors of the central nervous system. World Health Organization, Geneva
17.
Zurück zum Zitat McNeil DE, Cote TR, Clegg L, Mauer A (2002) SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia. Med Pediatr Oncol 39:554–557; discussion 552–553 McNeil DE, Cote TR, Clegg L, Mauer A (2002) SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia. Med Pediatr Oncol 39:554–557; discussion 552–553
18.
Zurück zum Zitat Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsić A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3:e3088. doi:10.1371/journal.pone.0003088 PubMedCentralPubMedCrossRef Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsić A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3:e3088. doi:10.​1371/​journal.​pone.​0003088 PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408–1414. doi:10.1200/JCO.2009.27.4324 PubMedCrossRef Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408–1414. doi:10.​1200/​JCO.​2009.​27.​4324 PubMedCrossRef
20.
Zurück zum Zitat Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924–1931. doi:10.1200/JCO.2005.04.4974 PubMedCrossRef Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924–1931. doi:10.​1200/​JCO.​2005.​04.​4974 PubMedCrossRef
21.
Zurück zum Zitat Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, Smith DR, Gerhard DS, Fults DW, VandenBerg S, Berger MS, Marie SK, Shinjo SM, Clara C, Phillips PC, Minturn JE, Biegel JA, Judkins AR, Resnick AC, Storm PB, Curran T, He Y, Rasheed BA, Friedman HS, Keir ST, McLendon R, Northcott PA, Taylor MD, Burger PC, Riggins GJ, Karchin R, Parmigiani G, Bigner DD, Yan H, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2011) The genetic landscape of the childhood cancer medulloblastoma. Science 331:435–439. doi:10.1126/science.1198056 PubMedCentralPubMedCrossRef Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, Smith DR, Gerhard DS, Fults DW, VandenBerg S, Berger MS, Marie SK, Shinjo SM, Clara C, Phillips PC, Minturn JE, Biegel JA, Judkins AR, Resnick AC, Storm PB, Curran T, He Y, Rasheed BA, Friedman HS, Keir ST, McLendon R, Northcott PA, Taylor MD, Burger PC, Riggins GJ, Karchin R, Parmigiani G, Bigner DD, Yan H, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE (2011) The genetic landscape of the childhood cancer medulloblastoma. Science 331:435–439. doi:10.​1126/​science.​1198056 PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Kleihues P, Cavenee WK (eds) (2000) World Health Organisation classification of tumours: pathology and genetics of tumours of the nervous system. IARC Press, Lyon Kleihues P, Cavenee WK (eds) (2000) World Health Organisation classification of tumours: pathology and genetics of tumours of the nervous system. IARC Press, Lyon
24.
Zurück zum Zitat Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442. doi:10.1038/415436a415436a PubMedCrossRef Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436–442. doi:10.​1038/​415436a415436a PubMedCrossRef
25.
Zurück zum Zitat McNeil DE, Cote TR, Clegg L, Rorke LB (2002) Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results. Med Pediatr Oncol 39:190–194PubMedCrossRef McNeil DE, Cote TR, Clegg L, Rorke LB (2002) Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results. Med Pediatr Oncol 39:190–194PubMedCrossRef
26.
Zurück zum Zitat Louis DNOH, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system. IARC, Lyon Louis DNOH, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system. IARC, Lyon
27.
Zurück zum Zitat Steinberg EP, Sisk JE, Locke KE (1985) X-ray CT and magnetic resonance imagers. Diffusion patterns and policy issues. N Engl J Med 313:859–864PubMedCrossRef Steinberg EP, Sisk JE, Locke KE (1985) X-ray CT and magnetic resonance imagers. Diffusion patterns and policy issues. N Engl J Med 313:859–864PubMedCrossRef
28.
Zurück zum Zitat U.S. Government Accountability Office (2008) Medicare part B imaging services: rapid spending growth and shift to physician offices indicate need for CMS to consider additional management practices (GAO-08-452). Government Printing Office, Washington, DC, pp 5–13 U.S. Government Accountability Office (2008) Medicare part B imaging services: rapid spending growth and shift to physician offices indicate need for CMS to consider additional management practices (GAO-08-452). Government Printing Office, Washington, DC, pp 5–13
29.
Zurück zum Zitat Davis FG, Malmer BS, Aldape K, Barnholtz-Sloan JS, Bondy ML, Brannstrom T, Bruner JM, Burger PC, Collins VP, Inskip PD, Kruchko C, McCarthy BJ, McLendon RE, Sadetzki S, Tihan T, Wrensch MR, Buffler PA (2008) Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 17:484–489PubMedCrossRef Davis FG, Malmer BS, Aldape K, Barnholtz-Sloan JS, Bondy ML, Brannstrom T, Bruner JM, Burger PC, Collins VP, Inskip PD, Kruchko C, McCarthy BJ, McLendon RE, Sadetzki S, Tihan T, Wrensch MR, Buffler PA (2008) Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 17:484–489PubMedCrossRef
31.
Zurück zum Zitat Kazner E, Wende S, Grumme T, Stochdorph FR, Claussen C (eds) (1989) Computed tomography and magnetic resonance tomography of intracranial tumors—a clinical perspective. Springer, Berlin Kazner E, Wende S, Grumme T, Stochdorph FR, Claussen C (eds) (1989) Computed tomography and magnetic resonance tomography of intracranial tumors—a clinical perspective. Springer, Berlin
32.
Zurück zum Zitat Guendelman S, Angulo V, Oman D (2005) Access to health care for children and adolescents in working poor families: recent findings from California. Med Care 43:68–78PubMed Guendelman S, Angulo V, Oman D (2005) Access to health care for children and adolescents in working poor families: recent findings from California. Med Care 43:68–78PubMed
33.
Zurück zum Zitat Gurney JG, Kadan-Lottick N (2001) Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 13:160–166PubMedCrossRef Gurney JG, Kadan-Lottick N (2001) Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 13:160–166PubMedCrossRef
Metadaten
Titel
Trends in childhood brain tumor incidence, 1973–2009
verfasst von
Roberta McKean-Cowdin
Pedram Razavi
Jessica Barrington-Trimis
Rachel Tobias Baldwin
Shahab Asgharzadeh
Myles Cockburn
Tarik Tihan
Susan Preston-Martin
Publikationsdatum
01.11.2013
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2013
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-013-1212-5

Weitere Artikel der Ausgabe 2/2013

Journal of Neuro-Oncology 2/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.